Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 3Phase NA 2Phase 3 2Phase 1/2 1

Status

Completed 6Terminated 5Recruiting 3Active not recruiting 3Unknown 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Breast 2Thoracic 1Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 102Breast Neoplasms 80Neoplasms 72Melanoma 63Neoplasm Metastasis 62Leukemia, Myeloid, Acute 58Ovarian Neoplasms 54Lymphoma, Non-Hodgkin 53Multiple Myeloma 51Prostatic Neoplasms 50Colorectal Neoplasms 50Glioblastoma 48Pancreatic Neoplasms 47Lung Neoplasms 45Recurrence 42Carcinoma, Renal Cell 40Squamous Cell Carcinoma of Head and Neck 37Leukemia, Lymphocytic, Chronic, B-Cell 37Triple Negative Breast Neoplasms 35Myelodysplastic Syndromes 30Lymphoma, Large B-Cell, Diffuse 28Glioma 28Stomach Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, B-Cell 27Brain Neoplasms 27Lymphoma, Follicular 26Endometrial Neoplasms 26Lymphoma 25Carcinoma, Hepatocellular 24

Interventions

testosterone 17 beta-cypionate 1pembrolizumab 1Testosterone Propionate 1Standard of Care 1Practice Guidelines as Topic 1Methyltestosterone 1Doxycycline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Active not recruiting × Urologic Neoplasms × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

NCT06238479 2026-05-22

EXCEED

Eli Lilly and Company

Phase 1 Active not recruiting
490 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Ureteral Neoplasms, Urologic Neoplasms, Triple Negative Breast Neoplasms

NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
18 enrolled
BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡